0001486189-23-000023.txt : 20230705
0001486189-23-000023.hdr.sgml : 20230705
20230705135521
ACCESSION NUMBER: 0001486189-23-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lau Stanley K.
CENTRAL INDEX KEY: 0001950824
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41097
FILM NUMBER: 231067776
MAIL ADDRESS:
STREET 1: C/O CARDIO DIAGNOSTICS HOLDINGS INC.
STREET 2: 400 N. ABERDEEN ST., SUITE 900
CITY: CHICAGO
STATE: IL
ZIP: 60642
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardio Diagnostics Holdings, Inc.
CENTRAL INDEX KEY: 0001870144
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870925574
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 N ABERDEEN ST, SUITE 900
CITY: CHICAGO
STATE: IL
ZIP: 60642
BUSINESS PHONE: 855-226-9991
MAIL ADDRESS:
STREET 1: 400 N ABERDEEN ST, SUITE 900
CITY: CHICAGO
STATE: IL
ZIP: 60642
FORMER COMPANY:
FORMER CONFORMED NAME: Mana Capital Acquisition Corp.
DATE OF NAME CHANGE: 20210629
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-06-30
0
0001870144
Cardio Diagnostics Holdings, Inc.
CDIO
0001950824
Lau Stanley K.
C/O CARDIO DIAGNOSTICS HOLDINGS INC.
400 N. ABERDEEN ST., SUITE 900
CHICAGO
IL
60642
1
0
0
0
0
Common Stock
2023-06-30
4
M
0
21008
1.19
A
21008
D
Common Stock
2023-07-01
4
M
0
8403
1.19
A
29411
D
Restricted Stock Units
0
2023-06-30
4
M
0
25000
0
A
2023-06-30
2023-12-31
Common Stock
25000
25000
D
Restricted Stock Units
0
2023-07-01
4
M
0
14000
0
A
2023-07-01
2024-01-31
Common Stock
14000
39000
D
Represents the settlement of restricted stock units (RSUs) that vested on June 30, 2023 through the issuance of shares of Common Stock.
Represents the settlement of restricted stock units (RSUs) that vested on July 1, 2023 through the issuance of shares of Common Stock.
Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On June 30, 2023, $25,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.
On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.
The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.
Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On July 1, 2023, $10,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.
On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on July 31, 2023, (ii) $2,000 in value on August 31, 2023, (iii) $2,000 in value on September 30, 2023; (iv) $2,000 in value on October 31, 2023; (v) $2,000 in value on November 30, 2023; (vi) $2,000 in value on December 31, 2023 and (vii) $2,000 in value on January 31, 2024.
/s/ Elisa Luqman as attorney-in-fact for Stanley Lau
2023-07-05